151. Do patients with intake of drugs labelled as sleep disturbing really sleep worse? A population based assessment from the Heinz Nixdorf Recall Study
- Author
-
Nico Dragano, Bernd Kowall, Andreas Stang, Anna-Therese Lehnich, Andrea Schmidt-Pokrzywniak, Karl-Heinz Jöckel, Gerhard Weinreich, Oliver Kuß, Susanne Moebus, and Raimund Erbel
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Drug-Related Side Effects and Adverse Reactions ,Population ,adverse drug reaction ,Medizin ,Arousal ,03 medical and health sciences ,symbols.namesake ,0302 clinical medicine ,Germany ,Sleep Initiation and Maintenance Disorders ,Surveys and Questionnaires ,medicine ,Prevalence ,Humans ,Pharmacology (medical) ,Generalizability theory ,summary of product characteristics ,030212 general & internal medicine ,Poisson regression ,education ,Psychiatry ,Morning ,Aged ,Drug Labeling ,Pharmacology ,Polypharmacy ,education.field_of_study ,business.industry ,Pharmacoepidemiology ,610 Medical sciences ,Medicine ,Middle Aged ,Sleep in non-human animals ,Confidence interval ,ddc: 610 ,symbols ,Female ,Self Report ,business ,030217 neurology & neurosurgery - Abstract
Introduction: There is only limited quantitative information on the association between intake of sleep disturbing drugs and nocturnal sleep disturbances. Information on sleep disturbing effects of drugs mostly derives from clinical trials with highly selected patient collectives. As these patient collectives[for full text, please go to the a.m. URL], GMDS 2015; 60. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS)
- Published
- 2016